Clinical Trial Update: Innovative Strategies For Risk Reduction Following CABG [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating innovative risk-reduction strategies after coronary artery bypass grafting has completed. The trial was sponsored by Un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Unity Health Toronto | Conditions: Coronary Artery Disease, Type II Diabetes Mellitus | Phase 2 | Status: COMPLETED